The optimization of recombinant antibody production in Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. Multiple strategies are employed to antibody titer, including process parameter optimization, cell line development, and implementation of perfusion systems. Fine-tuning growth parameters plays a c